Latest Headlines

  1. Connectivity – Key To Future-Oriented Medical Care

    Phillips-Medisize’s stand 1E28 at Medtec Europe, Stuttgart/Germany, April 4th to 6th, 2017, is designed for medical device professionals to discuss future products – from the first idea through to engineered-in scalability and batch production respectively. Several display cases reveal a clear view of numerous medical, diagnostic and drug delivery devices. They serve the discussion partners – potential customers, OEM manufacturers and the experts from Phillips-Medisize – as illustrative material to determine the typical steps and processes from the first model component to the ready-for-use solution.

  2. Blocking Certain Immune Cells Could Prevent Scar Tissue From Forming On Implants

    New research has shown that, by selectively blocking certain immune cells, scientists may be able to prevent the formation of scar tissue on implanted medical devices, which could substantially improve their biocompatibility and extend their functional use.

  3. Wirelessly Powered Pacemaker Implanted In A Pig

    Advances in technology engineered at the National University of Singapore (NUS) and Stanford University have improved the efficiency of energy transfers of electromagnetic power through tissue, effectively powering a pacemaker implanted in an adult pig.

  4. FDA Officials Make A Case For Re-Authorization Of User Fees Before Senate Committee

    Top officials of the U.S Food and Drug Administration (FDA) testified before a Senate HELP (Health, Education, Labor, Pensions) Committee to stress the rationale for re-authorizing user fee programs designed to streamline regulation and speed access to innovative and lifesaving medical products.

  5. J&J’s Ethicon Completes Torax Acquisition

    Ethicon* today announced the completion of its acquisition of Torax Medical, Inc., a privately held medical device company that manufactures and markets the LINX™ Reflux Management System for the surgical treatment of Gastroesophageal Reflux Disease (GERD).

  6. BioStable’s Aortic Annuloplasty Device Gains FDA Clearance

    BioStable Science & Engineering, Inc. announced recently it has received FDA market clearance for the HAART 300 Aortic Annuloplasty Device, the first commercially available internal annuloplasty device designed for aortic valve repair. BioStable expects the HAART 300 Aortic Annuloplasty Device to be available to select U.S. heart centers in the summer of 2017.

  7. FDA Delays Final Rule On Off-Label Promotion By One Year

    The U.S. Food and Drug Administration (FDA) is suspending the effectivity of its final rule on off-label promotion for another year.

  8. Minimally-Invasive Brain Imaging May Be Possible With Surgical Needles

    By substituting a glass surgical needle for the endoscope, a proof-of-concept study in mice has demonstrated technology that might lead to a minimally invasive method for imaging deep brain tissue, one that could provide a better understanding of neurological conditions.

  9. Medtronic’s Updated Evolut Pro TAVR Gains FDA Approval

    Medtronic plc recently announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve Evolut PRO valve for the treatment of severe aortic stenosis for symptomatic patients who are at high or extreme risk for open heart surgery. 

  10. Siemens Healthineers Combines CT Technology With HeartFlow’s Non-Invasive CAD Diagnostic

    Future generations of Siemens Healthineers’ computed tomography (CT) machines will include the only commercially available diagnostic tool capable of collecting fractional flow reserve (FFR) data for coronary artery disease (CAD) non-invasively.